4 unchanged sentences
EXHIBIT NUMBER
−Removed: Certificate of Change to Articles of Incorporation , filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 12, 2023.
Certification of Jeffrey F.
3 unchanged sentences
Eisenberg, Principal Executive Officer, and James Parslow, Principal Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in inline XBRL, include:
+Added: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in inline XBRL, include:
(i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Stockholders’ Equity, (iv) Condensed Consolidated Statements of Cash Flows and (v) the Notes to the Condensed Consolidated Financial Statements.
6 unchanged sentences
Xenetic Biosciences, Inc.
−Removed: August 10, 2023
+Added: November 9, 2023
/S/ JEFFREY F.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.